Regeneron Pharmaceuticals

REGNNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$82.176 B

$798.17 +1.70%

Close of 21 Sept 2026

Revenue

$14.3B

#313 by revenue

Earnings

$4.50B

#108 by earnings

Shares outstanding

106,800,000

Latest filing cover page

P/E ratio

18.2

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#12SanofiSNY$103.7B
#13GSKGSK$103.3B
#14Regeneron PharmaceuticalsREGN$82.2B
#15Takeda PharmaceuticalTAK$59.7B
#16Teva Pharmaceutical IndustriesTEVA$46.7B

What if Regeneron Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.3T

$294,051.36

Per share 368× higher

Bitcoin $1.72T

$16,704.42

Per share 20.9× higher

Nvidia $5.48T

$53,225.77

Per share 66.7× higher

Or at a round number

$100.0B $200.0B $500.0B $1.00T

Where these numbers come from

Share counts and financials for Regeneron Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.